Back to search results

Wearable Sensor Platform for Frontotemporal Dementia Monitoring

This study is looking at how well wearable sensors can track symptoms and how people with Frontotemporal Lobar Degeneration (FTLD) syndromes are functioning. Researchers will use these sensors, along with speech, movement, and thinking tests, to create new ways to measure changes in conditions like Frontotemporal Dementia (FTD) and Corticobasal Syndrome (CBS). They aim to enroll 60 participants aged 40 or older who have a diagnosis of possible or probable FTLD. The study will monitor physical activity and hand function over 24 months. The goal is to see if these digital tools can provide valuable information about FTLD syndromes.

Study design
This is an observational study, meaning it watches participants over time without giving new treatments. It plans to enroll 60 participants.
What's involved
You would be monitored for 24 months with study visits every 6 months. This involves using wearable sensors and completing speech, movement, and thinking assessments.
Compensation
Not stated in the trial record.
Follow-up
Participants will be monitored for 24 months, with primary endpoints measured at 24 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07569367

A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum

Not Yet Recruiting
Not specifiedAges 40+Observational
BioSensics
~60 participants
Updated 2026-05-08 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Physical Activity Monitoring
Measured over 24 months
+1 more outcome measured

Conditions

Frontotemporal Lobar Degeneration (FTLD)
Frontotemporal Dementia (FTD)
Corticobasal Degeneration
Corticobasal Syndrome (CBS)

Explore related trials

Corticobasal DegenerationCorticobasal syndromeFrontotemporal DementiaGRN-related frontotemporal dementia

Where it's being run

2 sites across 2 states
Maryland1
Massachusetts1

Who to contact

Claudia Waddell
[email protected]
410-502-3290
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male and female participants aged 40 years or older with a clinical diagnosis of possible or probable FTLD syndrome phenotype.
Participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment.
Individuals eligible for inclusion must be able to comply with the protocol per the investigator's judgment and must have a caregiver or study partner who is willing and able to assist with all study-related procedures.

Exclusion

Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment.
Individuals who have a history of frequent falls defined as more than 5 falls per month.

What this trial measures

  • Physical Activity Monitoring24 months

    Following each clinical visit, participants will be asked to wear a PAMSys pendant sensor and two PAMSys ULM wrist sensors for 14 days at home. The average daily number of steps will be measured using the PAMSys pendant.

  • Hand Function Monitoring24 months

    Following each clinical visit, participants will be asked to wear two PAMSys ULM wrist sensors for 14 days at home. Average daily number of hand goal-directed movements will be measured using the PAMSys ULM wrist sensors.